Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Bausch & Lomb Corp Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"BAUSCH + LOMB CORPORATION $1,400,000,000 8.375% SENIOR SECURED NOTES DUE 2028 INDENTURE DATED AS OF SEPTEMBER 29, 2023",
"Credit Agreement, as amended by the First Incremental Amendment, by and among Bausch + Lomb Corporation, certain subsidiaries of Bausch + Lomb Corporation as subsidiary guarantors, the lenders party thereto, Citibank, N.A., as collateral agent thereto, Goldman Sachs Bank USA, as term facility administrative agent thereto and JPMorgan Chase Bank, N.A., as first incremental term facility administrative agent thereto",
"Bausch + Lomb Completes Acquisition of XIIDRA ®"
08/02/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/02/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
07/07/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Stock and Asset Purchase Agreement by and among Buyer, Novartis and, for the limited purposes set forth therein, the Company",
"Stock and Asset Purchase Agreement by and among Buyer, Novartis and, for the limited purposes set forth therein, the Company"
06/30/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Bausch + Lomb Will Acquire XIIDRA ®"
06/01/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Bausch + Lomb Announces Key Leadership Changes VAUGHAN, Ontario, June 1, 2023 – Bausch + Lomb Corporation , a leading global eye health company dedicated to helping people see better to live better, announced a reshaping of its executive leadership team, including the elevation of all business unit heads. Luc Bonnefoy, senior vice president , Surgical; John Ferris, SVP, Consumer; and Yang Yang, SVP, Vision Care; will join the executive management team of the Company reporting directly to Brent Saunders, chairman and CEO. Concurrent with this change, Joseph Gordon, president, Global Consumer, Surgical and Vision Care, will transition to the role of Strategic Advisor to Saunders. Additionally, Louis Yu, Ph.D., executive vice president and Chief Quality Officer, has notified Bausch + Lomb of ..."
05/03/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/03/2023 8-K Quarterly results
04/26/2023 8-K Quarterly results
03/13/2023 ARS Form ARS - Annual Report to Security Holders:
03/13/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/13/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
02/22/2023 10-K Annual Report for the period ended December 31, 2022
02/22/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Bausch + Lomb Announces Fourth-Quarter and Full-Year 2022 Results"
02/14/2023 SC 13G Bausch Health Companies Inc. reports a 88.7% stake in Bausch + Lomb Corporation
11/02/2022 10-Q Quarterly Report for the period ended September 30, 2022
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
07/27/2022 8-K Quarterly results
07/20/2022 8-K Quarterly results
06/23/2022 8-K Quarterly results
06/08/2022 10-Q Quarterly Report for the period ended March 31, 2022
06/08/2022 8-K Quarterly results
05/17/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
05/05/2022 CERT Form CERT - Certification by an exchange approving securities for listing:
05/05/2022 8-A12B Form 8-A12B - Registration of securities [Section 12(b)]:
04/28/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
03/30/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
01/13/2022 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy